This study demonstrated that GADA, whether detected by RBA or ECL assays, recognised a clinical phenotype distinct from type 2 diabetes in adult-onset diabetes patients, in that individuals were leaner, with a higher frequency of multiple autoantibodies and earlier need for insulin therapy. Here, INS is linked to type 2 diabetes mellitus.